Fatigue, a common clinical complaint, often poses a diagnostic challenge to healthcare providers due to its multifactorial etiology. It requires a comprehensive and systematic approach for accurate diagnosis and effective management.
While fatigue may be a symptom of various diseases, it can also be a result of lifestyle factors. A detailed patient history and physical examination are crucial first steps in identifying potential causes. It is important to consider both physical and mental health conditions, as fatigue can be a symptom of disorders such as anemia, diabetes, thyroid disease, depression, and anxiety.
Investigations should be guided by the clinical history and examination findings. Basic tests include complete blood count, glucose level, electrolyte panel, and thyroid function tests. Additional investigations, such as sleep studies or psychiatric evaluations, may be necessary based on initial findings.
Management of fatigue involves treating the underlying cause, if identified. This could involve medication for medical conditions, or psychotherapy and lifestyle modifications for mental health or lifestyle-related causes. In cases where no clear cause is identified, symptom management and supportive care are crucial. This may involve cognitive-behavioral therapy, graded exercise therapy, and strategies to improve sleep hygiene and manage stress.
Prognosis varies greatly depending on the underlying cause. Regular follow-up is essential to monitor response to treatment and adjust management strategies as needed. It is also important to reassess patients periodically for the development of new symptoms or conditions that could contribute to fatigue.
Fatigue is a complex symptom that requires a comprehensive clinical approach for effective diagnosis and management. By implementing a systematic approach and considering a wide range of potential causes, healthcare providers can improve patient outcomes and quality of life.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation